Consulting firm McKinsey & Co has agreed to pay $230 million to resolve lawsuits by hundreds of U.S. local governments and school districts alleging it fueled an epidemic of opioid addiction through its work for bankrupt OxyContin maker Purdue Pharma and other drug companies.

Consulting firm McKinsey & Co. has agreed to pay $230 million to resolve lawsuits by hundreds of U.S. local governments and school districts alleging it fueled an epidemic of opioid addiction through its work for bankrupt OxyContin maker Purdue Pharma and other drug companies.

Hundreds of US local governments and school districts alleged it fuelled an epidemic of addiction through its work for bankrupt OxyContin maker Purdue Pharma.

McKinsey & Co. is poised to pay $230 million in its latest settlement of lawsuits blaming the company for its role advising opioid manufacturers in their sales of the painkillers.The proposed accord with local governments and school districts filed in court Tuesday would resolve allegations that McKinsey,

The settlements, which are pending judicial approval, were unveiled in documents sent on Tuesday in federal court in San Francisco. This substantial sum is in addition to the $641.5 million that McKinsey had already paid to resolve claims lodged by state attorneys-general.